DUBAI, United Arab Emirates, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Future Market Insights estimates that the Hyperphosphatemia Market will experience a rapid expansion between the years 2023 and 2033. By ...

New York, March 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hyperphosphatemia Treatment Global Market Report 2023" - https ...

Please provide your email address to receive an email when new articles are posted on . Phase 3 results from the PHREEDOM study demonstrated treatment with tenapanor safely and effectively decreased ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription The kidneys, in addition to removing toxins, ...

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation. Current phosphate management options, including dietary ...

Diabetes, COPD Raise Post-Kidney Transplant Readmission Rates High phosphate levels are associated with 3.3-fold increased odds of 28-day in-hospital mortality. Hyperphosphatemia predicts an increased ...

Nov. 4, 2002 — Lanthanum carbonate (Fosrenol) is safe and effective for the treatment of hemodialysis patients with hyperphosphatemia, according to two presentations on Nov. 2 at the American Society ...

Tenapanor, a novel agent that has been submitted to the US Food and Drug Administration (FDA) for approval for the treatment of hyperphosphatemia in patients undergoing dialysis, moved a step closer ...

Future Market Insights projects that between 2023 and 2033, the hyperphosphatemia market would grow rapidly. The global market for pharmaceuticals treating hyperphosphatemia is predicted to expand at ...

Hyperphosphatemia Treatment Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 The Business Research Company's Hyperphosphatemia Treatment Global Market Report 2022 – ...